OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Obesity and menopause
Santiago Palacios, Peter Chedraui, Rafael Sánchez-Borrego, et al.
Gynecological Endocrinology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 12

Menopause and metabolic dysfunction-associated steatotic liver disease
Stergios A. Pοlyzos, Dimitrios G. Goulis
Maturitas (2024) Vol. 186, pp. 108024-108024
Closed Access | Times Cited: 9

Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper
Nick Panay, Seng Bin Ang, Rebecca Cheshire, et al.
Climacteric (2024) Vol. 27, Iss. 5, pp. 441-457
Open Access | Times Cited: 8

Hormone Therapy (I): Estrogens, Progestogens, and Androgens
Francisco Quereda
(2025), pp. 211-229
Closed Access

Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health
Rossella E. Nappi, Tim Hillard
Climacteric (2025) Vol. 28, Iss. 1, pp. 1-3
Closed Access

Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
Helen Michaela de Oliveira, César Antonio González-Díaz, Lívia Mirelle Barbosa, et al.
Maturitas (2025) Vol. 195, pp. 108220-108220
Closed Access

Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted
Tomi S. Mikkola, Olavi Ylikorkala
Climacteric (2024) Vol. 27, Iss. 1, pp. 41-46
Closed Access | Times Cited: 3

Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis
Pluvio Coronado, Ana María Gómez, Eva Iglesias, et al.
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 3, pp. 234-242
Closed Access | Times Cited: 3

Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study
Ingrid Heuch, Ivar Heuch, Knut Hagen, et al.
BMC Musculoskeletal Disorders (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6

POESIT recommendations on management of body-identical hormones in menopausal symptoms
Santiago Palacios, Cláudio Rebelo, Ana Casquilho, et al.
Climacteric (2024) Vol. 27, Iss. 4, pp. 340-350
Closed Access | Times Cited: 1

Menopause hormone treatment after cancer
Anne Gompel
Climacteric (2023) Vol. 26, Iss. 3, pp. 240-247
Open Access | Times Cited: 3

Breast cancer survivals and hormone therapy: estrogen and melatonin
José Maria Soares, Bruna Salani Mota, Gabriela Bezerra Nobrega, et al.
Revista da Associação Médica Brasileira (2023) Vol. 69, Iss. 10
Open Access | Times Cited: 3

Hormonal Correction of Menopausal Disorders in Patients with Burdened Oncological History of Serous Ovarian Cancer
O. V. Yakushevskaya, S. V. Yureneva, Marina Averyanova, et al.
Doctor Ru (2024) Vol. 23, Iss. 2, pp. 49-54
Open Access

El papel del estetrol en la anticoncepción: una revisión integral
Manuel Sánchez‐Prieto, Cristina Llaneza-Suárez, Alejandro Beta, et al.
Revista chilena de obstetricia y ginecología (2024) Vol. 89, Iss. 3
Open Access

Endocrine Disorders and Sexuality II: Ovary
Camil Castelo‐Branco, Iuliia Naumova
Trends in andrology and sexual medicine (2024), pp. 187-201
Closed Access

Prevalencia y severidad de los síntomas de la menopausia en mujeres mayores de 60 años
Franklin Espitia de la Hoz
Revista Colombiana de Endocrinología Diabetes & Metabolismo (2024) Vol. 11, Iss. 1
Open Access

Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause
Laura Cucinella, Sara Tedeschi, Stefano Memoli, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-9
Closed Access

Exploring the potential for a set of UK hormone replacement therapy eligibility guidelines: A suggested proposal on the topic of venous thromboembolism
Abbie Laing, Lindsey J. Thomas, Tim Hillard, et al.
Post Reproductive Health (2023) Vol. 30, Iss. 1, pp. 39-54
Closed Access | Times Cited: 1

Eficacia y seguridad de una alternativa a la terapia hormonal de la menopausia: extracto purificado de polen
Manuel Sánchez‐Prieto, Eugenia Morillo, Natanael A. Domínguez-Osorio, et al.
Revista chilena de obstetricia y ginecología (2023) Vol. 88, Iss. 1
Open Access

Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review
Gabriel Fiol, Iñaki Lete, Laura Nieto, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5263-5263
Open Access

Page 1 - Next Page

Scroll to top